Literature DB >> 8245416

Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts.

A Satoh1, J Huard, C Labrecque, J P Tremblay.   

Abstract

A potential treatment for Duchenne muscular dystrophy (DMD) is injection of normal myoblasts into dystrophic muscles to induce formation of muscle fibers. To develop this therapy it is important to identify the injected myoblasts and the muscle fibers that they form in the host muscles. Fluorescent latex microspheres (FLMs) were used for this purpose in this study. Normal myoblasts were labeled with FLMs and injected into dystrophin-deficient (mdx) mice. The FLMs clearly indicated the location of injected myoblasts in the host muscle. Muscle fibers containing dystrophin were localized by immunofluorescence and immunoperoxidase. They were observed in clusters near the myoblasts labeled with FLMs. FLMs were also observed in some of these dystrophin-positive fibers in each cryostat section. These results indicate that: labeling myoblasts with FLMs can be used to trace the injected myoblasts in the muscle and to identify the muscle fibers that they formed; injected myoblasts remain near the injected site and do not migrate very far; most of the dystrophin-positive muscle fibers around the injected myoblasts result from fusion of the injected myoblasts; and the low percentage of dystrophin-positive muscle fibers is likely related to limited diffusion and lack of fusion of many injected myoblasts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245416     DOI: 10.1177/41.10.8245416

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  6 in total

1.  Slowing down differentiation of engrafted human myoblasts into immunodeficient mice correlates with increased proliferation and migration.

Authors:  Ingo Riederer; Elisa Negroni; Maximilien Bencze; Annie Wolff; Ahmed Aamiri; James P Di Santo; Suse D Silva-Barbosa; Gillian Butler-Browne; Wilson Savino; Vincent Mouly
Journal:  Mol Ther       Date:  2011-09-20       Impact factor: 11.454

2.  Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation.

Authors:  Maximilien Bencze; Elisa Negroni; Denis Vallese; Houda Yacoub-Youssef; Soraya Chaouch; Annie Wolff; Ahmed Aamiri; James P Di Santo; Bénédicte Chazaud; Gillian Butler-Browne; Wilson Savino; Vincent Mouly; Ingo Riederer
Journal:  Mol Ther       Date:  2012-10-16       Impact factor: 11.454

3.  A high-content, high-throughput siRNA screen identifies cyclin D2 as a potent regulator of muscle progenitor cell fusion and a target to enhance muscle regeneration.

Authors:  Michael V Khanjyan; Jonathan Yang; Refik Kayali; Thomas Caldwell; Carmen Bertoni
Journal:  Hum Mol Genet       Date:  2013-04-23       Impact factor: 6.150

4.  In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study.

Authors:  Elisa Negroni; Ingo Riederer; Soraya Chaouch; Marzia Belicchi; Paola Razini; James Di Santo; Yvan Torrente; Gillian S Butler-Browne; Vincent Mouly
Journal:  Mol Ther       Date:  2009-07-21       Impact factor: 11.454

5.  High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice.

Authors:  J Huard; S Verreault; R Roy; M Tremblay; J P Tremblay
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

6.  Desmin-lacZ transgene expression and regeneration within skeletal muscle transplants.

Authors:  L Lescaudron; S E Creuzet; Z Li; D Paulin; J Fontaine-Pérus
Journal:  J Muscle Res Cell Motil       Date:  1997-12       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.